Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee

Cancer Chemotherapy and Pharmacology
D M VigushinR C Coombes

Abstract

D-Limonene is a natural monoterpene with pronounced chemotherapeutic activity and minimal toxicity in preclinical studies. A phase I clinical trial to assess toxicity, the maximum tolerated dose (MTD) and pharmacokinetics in patients with advanced cancer was followed by a limited phase II evaluation in breast cancer. A group of 32 patients with refractory solid tumors completed 99 courses of D-limonene 0.5 to 12 g/m2 per day administered orally in 21-day cycles. Pharmacokinetics were analyzed by liquid chromatography-mass spectrometry. Ten additional breast cancer patients received 15 cycles of D-limonene at 8 g/m2 per day. Intratumoral monoterpene levels were measured in two patients. The MTD was 8 g/m2 per day; nausea, vomiting and diarrhea were dose limiting. One partial response in a breast cancer patient on 8 g/m2 per day was maintained for 11 months; three patients with colorectal carcinoma had prolonged stable disease. There were no responses in the phase II study. Peak plasma concentration (Cmax) for D-limonene ranged from 10.8+/-6.7 to 20.5+/-11.2 microM. Predominant circulating metabolites were perillic acid (Cmax 20.7+/-13.2 to 71+/-29.3 microM), dihydroperillic acid (Cmax 16.6+/-7.9 to 28.1+/-3.1 microM), limonene-1...Continue Reading

Citations

Jul 19, 2008·Breast Cancer Research and Treatment·Thangaiyan Rabi, Anupam Bishayee
May 4, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D R NewellUNKNOWN Cancer Research UK
Mar 17, 2000·Biochimica Et Biophysica Acta·M DemeuleR Béliveau
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J DonaldsonR C Coombes
Mar 14, 2003·Public Health Nutrition·Iman A HakimDavid Alberts
Apr 12, 2013·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Young Woo KimByung-Mu Lee
Jan 30, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Tamanna Jahangir, Sarwat Sultana
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·I C MouraE A Kimura
Jul 1, 2010·Pharmacognosy Reviews·S Jana, G S Shekhawat
Oct 5, 2011·World Journal of Hepatology·Roslin J Thoppil, Anupam Bishayee
Mar 4, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nada BezićJasna Puizina
Oct 25, 2012·Expert Opinion on Investigational Drugs·Min HuangYi-Tao Wang
Feb 6, 2010·European Journal of Medicinal Chemistry·K EffenbergerR Schobert
Dec 17, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Christopher D MannDavid P Berry
Mar 27, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Denise C ArrudaSilvia R B Uliana
Jun 2, 2007·Journal of Pharmaceutical and Biomedical Analysis·Shurong WangLiming Ye
Jul 14, 2011·British Journal of Pharmacology·Ethan B Russo
May 17, 2014·Phytotherapy Research : PTR·Jean-François LesgardsSylvia Pietri
Mar 22, 2005·International Immunopharmacology·Susana Del Toro-ArreolaAdrian Daneri-Navarro
Mar 13, 1999·Biochemical Pharmacology·I R HardcastleM Jarman
Jan 28, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Jaesuk Yun
Aug 31, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·V T de LimaA S N Formagio
Jul 6, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T B AdamsR L Smith
Oct 13, 2012·Cellular Immunology·Courtney M Lappas, Nicholas T Lappas
Dec 17, 2014·Archives of Biochemistry and Biophysics·Désirée MaßbergHanns Hatt
Jun 22, 2016·Archives of Toxicology·Lukas Schmidt, Thomas Göen
Aug 26, 2016·Pharmaceutical Biology·Ana Paula Gomes MouraMarianna Vieira Sobral
Jan 22, 2014·Journal of Proteome Research·Maj-Britt S AndersenLars O Dragsted
Aug 23, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chao YangJiong Chun
Jun 14, 2018·Physiological Reviews·Désirée Maßberg, Hanns Hatt
May 22, 2018·Network Modeling and Analysis in Health Informatics and Bioinformatics·Nagaraju ChinthakuntaSuresh Kumar Chitta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.